Does IMDEVIMAB Cause Dyspnoea? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Dyspnoea have been filed in association with IMDEVIMAB. This represents 19.4% of all adverse event reports for IMDEVIMAB.
84
Reports of Dyspnoea with IMDEVIMAB
19.4%
of all IMDEVIMAB reports
1
Deaths
48
Hospitalizations
How Dangerous Is Dyspnoea From IMDEVIMAB?
Of the 84 reports, 1 (1.2%) resulted in death, 48 (57.1%) required hospitalization, and 5 (6.0%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMDEVIMAB. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does IMDEVIMAB Cause?
Infusion related reaction (94)
Nausea (48)
Covid-19 pneumonia (42)
Hypoxia (40)
Pyrexia (39)
Oxygen saturation decreased (34)
Vomiting (32)
Dizziness (31)
Cough (27)
Flushing (27)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which IMDEVIMAB Alternatives Have Lower Dyspnoea Risk?
IMDEVIMAB vs IMEGLIMIN
IMDEVIMAB vs IMETELSTAT
IMDEVIMAB vs IMIDAPRIL
IMDEVIMAB vs IMIGLUCERASE
IMDEVIMAB vs IMIPENEM